These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 9806866)
1. Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice. Cross CE; Langhorne J Exp Parasitol; 1998 Nov; 90(3):220-9. PubMed ID: 9806866 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Linke A; Kühn R; Müller W; Honarvar N; Li C; Langhorne J Exp Parasitol; 1996 Nov; 84(2):253-63. PubMed ID: 8932775 [TBL] [Abstract][Full Text] [Related]
3. Comparison of pathology in susceptible A/J and resistant C57BL/6J mice after infection with different sub-strains of Plasmodium chabaudi. Hernandez-Valladares M; Naessens J; Nagda S; Musoke AJ; Rihet P; Ole-Moiyoi OK; Iraqi FA Exp Parasitol; 2004; 108(3-4):134-41. PubMed ID: 15582510 [TBL] [Abstract][Full Text] [Related]
4. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677 [TBL] [Abstract][Full Text] [Related]
5. Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice. Zhang Z; Chen L; Saito S; Kanagawa O; Sendo F Exp Parasitol; 2000 Nov; 96(3):121-9. PubMed ID: 11162362 [TBL] [Abstract][Full Text] [Related]
6. Pathology of Tnf-deficient mice infected with Plasmodium chabaudi adami 408XZ. Hernandez-Valladares M; Naessens J; Musoke AJ; Sekikawa K; Rihet P; Ole-Moiyoi OK; Busher P; Iraqi FA Exp Parasitol; 2006 Dec; 114(4):271-8. PubMed ID: 16716303 [TBL] [Abstract][Full Text] [Related]
7. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. Stevenson MM; Tam MF; Wolf SF; Sher A J Immunol; 1995 Sep; 155(5):2545-56. PubMed ID: 7650384 [TBL] [Abstract][Full Text] [Related]
8. Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria. Weidanz WP; Batchelder JM; Flaherty P; LaFleur G; Wong C; van der Heyde HC Exp Parasitol; 2005 Oct; 111(2):97-104. PubMed ID: 16087175 [TBL] [Abstract][Full Text] [Related]
9. Parasite genetic diversity does not influence TNF-mediated effects on the virulence of primary rodent malaria infections. Long GH; Chan BH; Allen JE; Read AF; Graham AL Parasitology; 2006 Dec; 133(Pt 6):673-84. PubMed ID: 16978451 [TBL] [Abstract][Full Text] [Related]
10. Plasmodium chabaudi chabaudi (AS): differential cellular responses to infection in resistant and susceptible mice. Seixas E; Ostler D Exp Parasitol; 2005 Aug; 110(4):394-405. PubMed ID: 15953500 [TBL] [Abstract][Full Text] [Related]
11. In vivo IL-12 production and IL-12 receptors beta1 and beta2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria. Sam H; Stevenson MM J Immunol; 1999 Feb; 162(3):1582-9. PubMed ID: 9973416 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. Jacobs P; Radzioch D; Stevenson MM J Immunol; 1995 Dec; 155(11):5306-13. PubMed ID: 7594544 [TBL] [Abstract][Full Text] [Related]
13. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. von der Weid T; Kopf M; Köhler G; Langhorne J Eur J Immunol; 1994 Oct; 24(10):2285-93. PubMed ID: 7925557 [TBL] [Abstract][Full Text] [Related]
14. Transient attenuated Foxp3 expression on CD4⁺ T cells treated with 7D4 mAb contributes to the control of parasite burden in DBA / 2 mice infected with lethal Plasmodium chabaudi chabaudi AS. Feng H; Zhu XT; Qi ZM; Wang QH; Wang GG; Pan YY; Li Y; Zheng L; Jiang YJ; Shang H; Cui L; Cao YM Scand J Immunol; 2012 Jan; 75(1):46-53. PubMed ID: 21916916 [TBL] [Abstract][Full Text] [Related]
15. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. Mohan K; Moulin P; Stevenson MM J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426 [TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice. Batchelder JM; Burns JM; Cigel FK; Lieberg H; Manning DD; Pepper BJ; Yañez DM; van der Heyde H; Weidanz WP Exp Parasitol; 2003 Oct; 105(2):159-66. PubMed ID: 14969693 [TBL] [Abstract][Full Text] [Related]
18. Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plasmodium chabaudi chabaudi AS infection. Clark K; Kulk N; Amante F; Haque A; Engwerda C Parasite Immunol; 2007 Mar; 29(3):153-8. PubMed ID: 17266742 [TBL] [Abstract][Full Text] [Related]
19. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype. Uzonna JE; Kaushik RS; Gordon JR; Tabel H J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites. Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]